Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and adverse events. De Martin E, Fulgenzi CAM, Celsa C, Laurent-Bellue A, et al. Gut 2025;74:1165-1177.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

De Martin E, Fulgenzi CAM, Celsa C, Laurent-Bellue A, et al. Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and adverse events. Gut 2025;74:1165-1177.
PMID: 39658265